Literature DB >> 11936882

Primary thoracic wall tumours of mesenchymal origin in dogs: a retrospective study of 46 cases.

S J Baines1, S Lewis, R A S White.   

Abstract

Forty-three of the chest wall tumours in 46 dogs were malignant; five had metastases apparent at the time of presentation, five more had metastases discovered intraoperatively. Surgical resection of the tumours was associated with a significantly better outcome than conservative management. The median survival times after surgery for dogs with osteosarcoma was 17 weeks, for dogs with fibrosarcoma it was 26 weeks and for dogs with chondrosarcoma it was 250 weeks. En bloc excision of primary tumours affecting the chest wall was associated with minimal morbidity, but long-term survival was limited by distant metastases, primarily to the lungs. The tumours recurred in only three dogs. Early, radical surgical excision is recommended in the management of tumours of the chest wall. The prognosis depends on the histologic type of tumour and a histological diagnosis is mandatory before excision.

Entities:  

Mesh:

Year:  2002        PMID: 11936882     DOI: 10.1136/vr.150.11.335

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  3 in total

1.  Retrospective analysis of use of fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG PET/CT) for detection of metastatic lymph nodes in dogs diagnosed with appendicular osteosarcoma.

Authors:  Powell T Slinkard; Elissa K Randall; Lynn R Griffin
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

2.  Prognostic value of fluorine18 flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma.

Authors:  Lynn R Griffin; Douglas H Thamm; Ariel Brody; Laura E Selmic
Journal:  J Vet Intern Med       Date:  2019-02-15       Impact factor: 3.333

3.  Axial Multicentric Osteosarcoma in an English Cocker Spaniel.

Authors:  B Parzefall; S De Decker; S Carvalho; R Terry; J Leach; K C Smith; A Lara-Garcia
Journal:  J Vet Intern Med       Date:  2016-08-13       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.